Autifony Therapeutics logo

Autifony Therapeutics

Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders

37 employees · est. 2011

VS
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc.

A neuroscience-focused biopharmaceutical company

333 employees · est. 1996 · Canada

Xenon Pharmaceuticals Inc. is the older company (2011 vs 1996); Xenon Pharmaceuticals Inc. is the larger of the two.

Side-by-Side Comparison

Autifony Therapeutics Xenon Pharmaceuticals Inc.
Founded
2011 1996 older
Headquarters
Not tracked yet Canada
Employees
37 333 larger
Industry
Biotechnology, Health and Wellness, Medical Devices Biopharma, Biotechnology, Health Care
Funding Stage
Series Unknown Post Ipo Equity
Total Funding
$27.00M $1.29B
Funding Rounds
5 13
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Medical Research, CNS Disorders, Drug Development, Ion Channel, Rare Genetic Diseases, Clinical Stage, Pharmaceuticals, Ion Channel Drug Discovery, Medicines, Genetic Medicine, Rare Diseases, Neurological Disorders, Neurology, Clinical Trials Biopharmaceuticals, Neuroscience, Drug Development, Ion Channels, Neurology, Epilepsy, Depression, Psychiatry, Seizures, Potassium Channels, Sodium Channels, Clinical Trials, Genetic Insights, Rare Genetic Disorders, Proprietary Discovery Platform
Website
autifony.com xenon-pharma.com
Autifony Therapeutics logo

About Autifony Therapeutics

Autifony Therapeutics, founded in 2011, is dedicated to developing new medicines to treat rare genetic CNS disorders. The company's slogan "Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders" encapsulates its mission. Specializing in Biotechnology, Health and Well...

Xenon Pharmaceuticals Inc. logo

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. The company was founded in 1996 and is headquartered in...

We will tell you when either one moves

BounceWatch watches Autifony Therapeutics and Xenon Pharmaceuticals Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Autifony Therapeutics and Xenon Pharmaceuticals... — by email.

Frequently Asked Questions

Autifony Therapeutics — Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders . Xenon Pharmaceuticals Inc. — A neuroscience-focused biopharmaceutical company. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Autifony Therapeutics has raised $27.00M while Xenon Pharmaceuticals Inc. has raised $1.29B.
Autifony Therapeutics and Xenon Pharmaceuticals Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Autifony Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Autifony Therapeutics on 11 Sep 2024, and Xenon Pharmaceuticals Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes